Chitosan-carboxymethylcellulose interpolymer complexes for gastric-specific delivery of clarithromycin

被引:28
作者
Gomez-Burgaz, M. [1 ]
Garcia-Ochoa, B. [1 ]
Torrado-Santiago, S. [1 ]
机构
[1] Univ Complutense, Fac Pharm, Dept Pharmaceut Technol, E-28040 Madrid, Spain
关键词
interpolymer complexes; chitosan; carboxymethylcellulose sodium; clarithromycin; gastroretentive systems;
D O I
10.1016/j.ijpharm.2008.03.042
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chitosan (CS) and carboxymethylcellulose (CMC) sodium interpolymer complexes were formed using the novel method "tablets-in-capsule" for stomach drug delivery. The aim of this study was to investigate the influence of the molecular weight (M.wt.) of CS and the proportion CS/CMC on physical properties and clarithromycin (CAM) release. Swelling was dependent on CS M.wt., on medium pH and on proportion polymer/polymer. The higher M.wt., the major presence of protonated amined moieties that can be ionized and modify the swelling/eroding and dissolution medium uptake capacity. Swelling kinetics at pH 1.2, were close to Fickian diffusion, whereas at pH 4.2 were non-Fickian. Furthermore, dissolution medium uptake capacity can be adjusted to an exponential equation at pH 1.2 (r(2) >= 0.96), and to a linear equation at pH 4.2 (r(2) >= 0.99), showing that at low pHs the repulsion among ionized chains is higher. CAM release rates have shown to be dependent on pH and on polymer proportion. At pH 1.2, the fastest profile was obtained when using high M.wt. CS. Drug diffusion was Fickian, so the process is governed by swelling/eroding. Whereas at pH 4.2, CAM release followed zero-order kinetics with no influence on M.wt. So, release is controlled by CAM low solubility. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:135 / 143
页数:9
相关论文
共 34 条
[1]   Gastroretentive dosage forms:: Overview and special case of Helicobacter pylori [J].
Bardonnet, PL ;
Faivre, V ;
Pugh, WJ ;
Piffaretti, JC ;
Falson, F .
JOURNAL OF CONTROLLED RELEASE, 2006, 111 (1-2) :1-18
[2]  
Chellat F, 2000, J BIOMED MATER RES, V53, P592, DOI 10.1002/1097-4636(200009)53:5<592::AID-JBM20>3.0.CO
[3]  
2-P
[4]   Preparation of mucoadhesive microspheres containing antimicrobial agents for eradication of H-pylori [J].
Chun, MK ;
Sah, H ;
Choi, HK .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 297 (1-2) :172-179
[5]   Matrices containing NaCMC and HPMC 1. Dissolution performance characterization [J].
Conti, S. . ;
Maggi, L. ;
Segale, L. ;
Machiste, E. Ochoa ;
Conte, U. ;
Grenier, P. ;
Vergnault, G. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 333 (1-2) :136-142
[6]   Matrices containing NaCMC and HPMC 2. Swelling and release mechanism study [J].
Conti, S. ;
Maggi, L. ;
Segale, L. ;
Machiste, E. Ochoa ;
Conte, U. ;
Grenier, P. ;
Vergnault, G. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 333 (1-2) :143-151
[7]   Drug delivery strategies for the treatment of Helicobacter pylori infections [J].
Conway, BR .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (06) :775-790
[8]   Poly (acrylic acid) chitosan interpolymer complexes for stomach controlled antibiotic delivery [J].
de la Torre, PM ;
Torrado, G ;
Torrado, S .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, 2005, 72B (01) :191-197
[9]  
de la Torre PM, 2003, BIOMATERIALS, V24, P1499
[10]  
DIMARIO F, 2006, WORLD J GASTROENTERO, V12, P2313